Information Library

Results for: Oncology - High-quality studies - Central Laboratories

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • The Molecular Biomarker Revolution in Non-Small Cell Lung Cancer

    White Paper — June 23, 2011
    In this new white paper Quintiles’ experts Christopher Ung, Jason Hill, Carrie Lee and Harish Dave review some of the most promising molecular pathways and targeted approaches for NSCLC, the critical role of diagnostics, and strategies to detect and address the emergence of resistance.

  • Quintiles and Population Genetics Technologies Partner

    Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

  • Dr. Frank Massam

    Hear from the Experts — May 13, 2011
    Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

  • Clinical – Smarter Trials, Accelerated Outcomes

    Brochure — February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Oncology Expertise - Scientific Collaborator for Global Solutions

    Brochure — January 28, 2011
    Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you.

  • QUINTILES ADDS TISSUE TESTING SERVICES IN CHINA

    Press Release — February 16, 2010 - Quintiles announced the availability of anatomic pathology services through its central laboratory in Beijing, China, to help biopharmaceutical companies develop more effective cancer treatments.

  • Validated Biomarker Menu

    Brochure — July 14, 2009
    A comprehensive menu of validated cell, fluid and tissue based biomarker assays.

  • QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS

    Press Release — May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments.

  • QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDITATION

    Press Release — March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network.

Page 1 of 1 (9 results)

Subscribe to Email Based on Your Interests

Set preferences